Free Trial
→ What is “gold skimming”? (From Brownstone Research) (Ad)tc pixel Free MXCT Stock Alerts

MaxCyte (MXCT) Competitors

MaxCyte logo
GBX 0.82 -0.03 (-3.13%)
As of 05/11/2026
Compare

MXCT vs. ADV, MAST, ABM, RGP, and LEAF

Should you buy MaxCyte stock or one of its competitors? MarketBeat compares MaxCyte with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with MaxCyte include Advance Energy (ADV), MAST Energy Developments (MAST), African Battery Metals (ABM), Ross Group (RGP), and Leaf Clean Energy (LEAF). These companies are all part of the "business services" industry.

How does MaxCyte compare to Advance Energy?

Advance Energy (LON:ADV) and MaxCyte (LON:MXCT) are both small-cap business services companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, profitability, earnings, dividends, valuation, media sentiment, analyst recommendations and institutional ownership.

Advance Energy has higher earnings, but lower revenue than MaxCyte. MaxCyte is trading at a lower price-to-earnings ratio than Advance Energy, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Advance Energy£16K0.00N/A-£0.60N/A
MaxCyte£33.03M0.03-£45.08M-£40.00N/A

In the previous week, Advance Energy had 4 more articles in the media than MaxCyte. MarketBeat recorded 5 mentions for Advance Energy and 1 mentions for MaxCyte. Advance Energy's average media sentiment score of 1.06 beat MaxCyte's score of 0.00 indicating that Advance Energy is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Advance Energy
2 Very Positive mention(s)
3 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
MaxCyte
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

24.0% of MaxCyte shares are owned by institutional investors. 1.9% of MaxCyte shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Advance Energy has a net margin of 0.00% compared to MaxCyte's net margin of -120.39%. Advance Energy's return on equity of 0.00% beat MaxCyte's return on equity.

Company Net Margins Return on Equity Return on Assets
Advance EnergyN/A N/A N/A
MaxCyte -120.39%-16.71%-11.07%

Summary

Advance Energy beats MaxCyte on 6 of the 10 factors compared between the two stocks.

How does MaxCyte compare to MAST Energy Developments?

MaxCyte (LON:MXCT) and MAST Energy Developments (LON:MAST) are both small-cap business services companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, risk, valuation, dividends, institutional ownership, profitability, analyst recommendations and media sentiment.

MAST Energy Developments has a net margin of 0.00% compared to MaxCyte's net margin of -120.39%. MaxCyte's return on equity of -16.71% beat MAST Energy Developments' return on equity.

Company Net Margins Return on Equity Return on Assets
MaxCyte-120.39% -16.71% -11.07%
MAST Energy Developments N/A -695.03%-14.56%

24.0% of MaxCyte shares are held by institutional investors. Comparatively, 0.2% of MAST Energy Developments shares are held by institutional investors. 1.9% of MaxCyte shares are held by company insiders. Comparatively, 3.5% of MAST Energy Developments shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

MAST Energy Developments has lower revenue, but higher earnings than MaxCyte. MAST Energy Developments is trading at a lower price-to-earnings ratio than MaxCyte, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MaxCyte£33.03M0.03-£45.08M-£40.00N/A
MAST Energy Developments£1.26M1.63-£3.26M-£13.60N/A

In the previous week, MaxCyte had 1 more articles in the media than MAST Energy Developments. MarketBeat recorded 1 mentions for MaxCyte and 0 mentions for MAST Energy Developments. MaxCyte's average media sentiment score of 0.00 equaled MAST Energy Developments'average media sentiment score.

Company Overall Sentiment
MaxCyte Neutral
MAST Energy Developments Neutral

MaxCyte has a beta of 1.13, meaning that its stock price is 13% more volatile than the broader market. Comparatively, MAST Energy Developments has a beta of -0.58, meaning that its stock price is 158% less volatile than the broader market.

Summary

MaxCyte beats MAST Energy Developments on 7 of the 12 factors compared between the two stocks.

How does MaxCyte compare to African Battery Metals?

MaxCyte (LON:MXCT) and African Battery Metals (LON:ABM) are both small-cap business services companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, risk, dividends, institutional ownership, profitability, valuation, analyst recommendations and media sentiment.

African Battery Metals has a net margin of 0.00% compared to MaxCyte's net margin of -120.39%. African Battery Metals' return on equity of 0.00% beat MaxCyte's return on equity.

Company Net Margins Return on Equity Return on Assets
MaxCyte-120.39% -16.71% -11.07%
African Battery Metals N/A N/A N/A

African Battery Metals has lower revenue, but higher earnings than MaxCyte. MaxCyte is trading at a lower price-to-earnings ratio than African Battery Metals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MaxCyte£33.03M0.03-£45.08M-£40.00N/A
African Battery MetalsN/AN/AN/A-£4.50N/A

24.0% of MaxCyte shares are held by institutional investors. 1.9% of MaxCyte shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, MaxCyte had 1 more articles in the media than African Battery Metals. MarketBeat recorded 1 mentions for MaxCyte and 0 mentions for African Battery Metals. MaxCyte's average media sentiment score of 0.00 equaled African Battery Metals'average media sentiment score.

Company Overall Sentiment
MaxCyte Neutral
African Battery Metals Neutral

Summary

MaxCyte beats African Battery Metals on 5 of the 9 factors compared between the two stocks.

How does MaxCyte compare to Ross Group?

Ross Group (LON:RGP) and MaxCyte (LON:MXCT) are both small-cap business services companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, valuation, dividends, profitability, institutional ownership, risk, analyst recommendations and media sentiment.

24.0% of MaxCyte shares are held by institutional investors. 21.0% of Ross Group shares are held by insiders. Comparatively, 1.9% of MaxCyte shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Ross Group has a net margin of 0.00% compared to MaxCyte's net margin of -120.39%. Ross Group's return on equity of 0.00% beat MaxCyte's return on equity.

Company Net Margins Return on Equity Return on Assets
Ross GroupN/A N/A -131.93%
MaxCyte -120.39%-16.71%-11.07%

Ross Group has a beta of 0.03, meaning that its share price is 97% less volatile than the broader market. Comparatively, MaxCyte has a beta of 1.13, meaning that its share price is 13% more volatile than the broader market.

In the previous week, MaxCyte had 1 more articles in the media than Ross Group. MarketBeat recorded 1 mentions for MaxCyte and 0 mentions for Ross Group. Ross Group's average media sentiment score of 0.00 equaled MaxCyte'saverage media sentiment score.

Company Overall Sentiment
Ross Group Neutral
MaxCyte Neutral

Ross Group has higher earnings, but lower revenue than MaxCyte.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ross Group£43K0.00-£3.18MN/AN/A
MaxCyte£33.03M0.03-£45.08M-£40.00N/A

Summary

MaxCyte beats Ross Group on 6 of the 10 factors compared between the two stocks.

How does MaxCyte compare to Leaf Clean Energy?

Leaf Clean Energy (LON:LEAF) and MaxCyte (LON:MXCT) are both small-cap business services companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, valuation, dividends, analyst recommendations, earnings, profitability and risk.

In the previous week, MaxCyte had 1 more articles in the media than Leaf Clean Energy. MarketBeat recorded 1 mentions for MaxCyte and 0 mentions for Leaf Clean Energy. Leaf Clean Energy's average media sentiment score of 0.00 equaled MaxCyte'saverage media sentiment score.

Company Overall Sentiment
Leaf Clean Energy Neutral
MaxCyte Neutral

24.0% of MaxCyte shares are held by institutional investors. 1.9% of MaxCyte shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Leaf Clean Energy has higher earnings, but lower revenue than MaxCyte. MaxCyte is trading at a lower price-to-earnings ratio than Leaf Clean Energy, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Leaf Clean Energy-£2M0.00N/A£142.80N/A
MaxCyte£33.03M0.03-£45.08M-£40.00N/A

Leaf Clean Energy has a net margin of 0.00% compared to MaxCyte's net margin of -120.39%. Leaf Clean Energy's return on equity of 0.00% beat MaxCyte's return on equity.

Company Net Margins Return on Equity Return on Assets
Leaf Clean EnergyN/A N/A N/A
MaxCyte -120.39%-16.71%-11.07%

Summary

Leaf Clean Energy beats MaxCyte on 5 of the 9 factors compared between the two stocks.

Get MaxCyte News Delivered to You Automatically

Sign up to receive the latest news and ratings for MXCT and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MXCT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MXCT vs. The Competition

Export
MetricMaxCyteMedical Devices IndustryMedical SectorLON Exchange
Market Cap£869K£2.07B£6.31B£2.79B
Dividend YieldN/A2.67%2.79%6.09%
P/E Ratio-0.0214.0321.03365.97
Price / Sales0.03131.10552.3488,465.78
Price / Cash1.9715.9942.9427.89
Price / Book0.004.639.837.71
Net Income-£45.08M£144.75M£3.55B£5.89B
7 Day Performance-3.06%-1.03%-0.52%0.51%
1 Month Performance3.22%2.33%1.20%2.49%
1 Year Performance-99.51%7.61%41.25%87.54%

MaxCyte Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MXCT
MaxCyte
N/AGBX 0.82
-3.1%		N/A-99.5%£869K£33.03MN/A80
ADV
Advance Energy
N/AN/AN/AN/A£2.67M£16KN/A75,000
MAST
MAST Energy Developments
N/AGBX 1.20
-19.5%		N/A+380.0%£2.06M£1.26MN/A29,900
ABM
African Battery Metals
N/AN/AN/AN/A£2.00MN/AN/A127,000
RGP
Ross Group
N/AN/AN/AN/A£1.63M£43KN/A4,260

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:MXCT) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners
Read this or regret it forever
Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” P...
Porter & Company | Sponsoredtc pixel
Before you buy SpaceX shares, consider this alternative approach
SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceedin...
Weiss Ratings | Sponsoredtc pixel
Collect $1,170 a month from silver
I've Rarely Seen This With Silver This combination - 20% dividends + 68% share appreciation - never happens...
Investors Alley | Sponsoredtc pixel
Elon’s Biggest Launch Ever: 15x Bigger Than SpaceX
The Man Who Called Nvidia Before It Soared 1,000% Issues New Elon Musk BUY Alert Luke Lango was ranked Amer...
InvestorPlace | Sponsoredtc pixel
This is the worst news for stocks in 50 years
Goldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...
TradeSmith | Sponsoredtc pixel
SpaceX just filed. The clock is ticking.
Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...
The Oxford Club | Sponsoredtc pixel
Is this AI lab Elon’s SpaceX lifeline?
Elon Musk went from calling one AI lab 'evil' to striking a deal giving it access to SpaceX's entire Colossus ...
Chaikin Analytics | Sponsoredtc pixel
Millionaire trader: “Buy this before May 15.”
Hedge fund legend Larry Benedict - who beat the S&P 500 by 18 times in 2025 and generated $95 million for clie...
Brownstone Research | Sponsoredtc pixel